Costs of multidisciplinary teams in cancer are small in relation to benefitsBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3700 (Published 28 May 2012) Cite this as: BMJ 2012;344:e3700
- Richard Simcock, consultant clinical oncologist1,
- Amelia Heaford, year 5 medical student2
- 1Brighton and Sussex University Hospitals NHS Trust, Park Centre for Breast Care, Brighton BN1 6AG, UK
- 2Brighton and Sussex Medical Schools, Brighton BN1 9PX, UK
To see evidence that multidisciplinary teams are effective in cancer is a relief, given the effort required to implement them.1 Whether their efficacy derives from surgical specialisation or the addition of members such as oncologists to the team is not clear.
Introducing multidisciplinary teams has come at huge organisational cost, particularly with respect …